Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

CSPC ZhongQi Pharmaceutical Technology Co: Clinical Trials & FDA Approval Profile

CSPC ZhongQi Pharmaceutical Technology Co (Global / Institutional) sponsors 79 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 27 active protocols (9 recruiting now), 8 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)10.1%
Median Closed Enrollment vs National (145 pts)192 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for CSPC ZhongQi Pharmaceutical Technology Co
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)79
Active Pipeline (Recruiting Now)27 (9)
Completed vs Stopped Early8 / 8 (10.1%)
Median Closed Actual Enrollment192 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With CSPC ZhongQi Pharmaceutical Technology Co
Hospital Research SiteLocationShared Protocols
Fudan University Shanghai Cancer CenterShanghai, Shanghai Municipality4
China-Japan Friendship HospitalBeijing, Beijing Municipality3
West China Hospital of Sichuan UniversityChengdu, Sichuan3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by CSPC ZhongQi Pharmaceutical Technology Co
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT04927481A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast CancerPhase IITERMINATED

Explore interactive annual charts and M&A subsidiary rollups in the CSPC ZhongQi Pharmaceutical Technology Co Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI